Related Experiment Video
Updated: Jul 17, 2026

A Rat Carotid Balloon Injury Model to Test Anti-vascular Remodeling Therapeutics
Published on: September 19, 2016
Vascular dysfunction in human and rat cirrhosis: role of receptor-desensitizing and calcium-sensitizing proteins
Martin Hennenberg1, Jonel Trebicka, Erwin Biecker
1Department of Internal Medicine I, University of Bonn, Bonn, Germany. Martin.Hennenberg@ukb.uni-bonn.de
Unlabelled:
In cirrhosis, vascular hypocontractility leads to vasodilation and contributes to portal hypertension. Impaired activation of contractile pathways contributes to vascular hypocontractility. Angiotensin II type 1 receptors (AT1-Rs) are coupled to the contraction-mediating RhoA/Rho-kinase pathway and may be desensitized by phosphorylation through G-protein-coupled receptor kinases (GRKs) and binding of beta-arrestin-2. In the present study, we analyzed vascular hypocontractility to angiotensin II in cirrhosis. Human hepatic arteries were obtained during liver transplantation. In rats, cirrhosis was induced by bile duct ligation (BDL). Contractility of rat aortic rings was measured myographically. Protein expression and phosphorylation were analyzed by Western blot analysis. Immunoprecipitation was performed with protein A-coupled Sepharose beads. Myosin light chain (MLC) phosphatase activity was assessed as dephosphorylation of MLCs. Aortas from BDL rats were hyporeactive to angiotensin II and extracellular Ca2+. Expression of AT1-R and Galphaq/11,12,13 remained unchanged in hypocontractile rat and human vessels, whereas GRK-2 and beta-arrestin-2 were up-regulated. The binding of beta-arrestin-2 to the AT1-R was increased in hypocontractile rat and human vessels. Inhibition of angiotensin II-induced aortic contraction by the Rho-kinase inhibitor Y-27632 was pronounced in BDL rats. Basal phosphorylation of the ROK-2 substrate moesin was reduced in vessels from rats and patients with cirrhosis. Analysis of the expression and phosphorylation of Ca(2+)-sensitizing proteins (MYPT1 and CPI-17) in vessels from rats and patients with cirrhosis suggested decreased Ca2+ sensitivity. Angiotensin II-stimulated moesin phosphorylation was decreased in aortas from BDL rats. MLC phosphatase activity was elevated in aortas from BDL rats.
Conclusion:
Vascular hypocontractility to angiotensin II in cirrhosis does not result from changes in expression of AT1-Rs or G-proteins. Our data suggest that in cirrhosis-induced vasodilation, the AT1-R is desensitized by GRK-2 and beta-arrestin-2 and that changed patterns of phosphorylated Ca(2+) sensitizing proteins decrease Ca(2+) sensitivity.
Insights
In cirrhosis, blood vessels become less responsive to angiotensin II due to desensitization of AT1-Rs by GRK-2 and beta-arrestin-2. This leads to decreased Ca2+ sensitivity and vasodilation, contributing to portal hypertension.
Area of Science:
- Cardiovascular Biology
- Hepatology
- Molecular Pharmacology
Background:
- Cirrhosis causes vascular hypocontractility, leading to vasodilation and portal hypertension.
- Impaired contractile pathway activation contributes to this vascular dysfunction.
- Angiotensin II type 1 receptors (AT1-Rs) are key in vascular contraction but can be desensitized.
Purpose of the Study:
- To investigate the mechanisms of vascular hypocontractility to angiotensin II in cirrhosis.
- To analyze the role of AT1-R signaling, G-proteins, GRKs, and beta-arrestin-2 in cirrhosis-associated vasodilation.
Main Methods:
- Used bile duct ligation (BDL) to induce cirrhosis in rats and analyzed human hepatic arteries.
- Measured vascular contractility using myography and assessed protein expression/phosphorylation via Western blot and immunoprecipitation.
- Evaluated myosin light chain (MLC) phosphatase activity and phosphorylation of Ca(2+)-sensitizing proteins.
Main Results:
- Aortas from BDL rats showed hyporeactivity to angiotensin II and reduced Ca2+ sensitivity.
- GRK-2 and beta-arrestin-2 were upregulated, with increased beta-arrestin-2 binding to AT1-R in cirrhotic vessels.
- Decreased phosphorylation of moesin and altered patterns of phosphorylated Ca(2+)-sensitizing proteins (MYPT1, CPI-17) were observed.
Conclusions:
- Cirrhosis-induced vascular hypocontractility to angiotensin II is not due to altered AT1-R or G-protein expression.
- AT1-R desensitization by GRK-2 and beta-arrestin-2, along with reduced Ca2+ sensitivity, contributes to vasodilation in cirrhosis.
Related Concept Videos
Cirrhosis II: Pathophysiology
Cirrhosis I: Introduction
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
Antihypertensive Drugs: Action of Calcium Channel Blockers
Antihypertensive Drugs: Vasodilators

